statistiche ricercatore

Continente	#
NA - Nord America	982
EU - Europa	677
AS - Asia	479
SA - Sud America	124
AF - Africa	18
Continente sconosciuto - Info sul continente non disponibili	1
Totale	2.281

Nazione	#
US - Stati Uniti d'America	971
RU - Federazione Russa	183
CN - Cina	133
SG - Singapore	126
IE - Irlanda	114
GB - Regno Unito	99
BR - Brasile	97
VN - Vietnam	90
IT - Italia	76
SE - Svezia	53
HK - Hong Kong	40
FR - Francia	30
DE - Germania	29
UA - Ucraina	29
IN - India	22
FI - Finlandia	19
KR - Corea	14
ZA - Sudafrica	13
AR - Argentina	10
TR - Turchia	10
NL - Olanda	9
AT - Austria	7
CA - Canada	7
BE - Belgio	6
BD - Bangladesh	5
CZ - Repubblica Ceca	5
ID - Indonesia	5
AZ - Azerbaigian	4
CH - Svizzera	4
JP - Giappone	4
KZ - Kazakistan	4
UZ - Uzbekistan	4
EC - Ecuador	3
EG - Egitto	3
ES - Italia	3
IQ - Iraq	3
MX - Messico	3
PK - Pakistan	3
PL - Polonia	3
PY - Paraguay	3
UY - Uruguay	3
VE - Venezuela	3
AE - Emirati Arabi Uniti	2
CO - Colombia	2
LT - Lituania	2
PT - Portogallo	2
SA - Arabia Saudita	2
A2 - ???statistics.table.value.countryCode.A2???	1
AL - Albania	1
BA - Bosnia-Erzegovina	1
BO - Bolivia	1
CL - Cile	1
CR - Costa Rica	1
GR - Grecia	1
IL - Israele	1
IR - Iran	1
MA - Marocco	1
NG - Nigeria	1
NO - Norvegia	1
NP - Nepal	1
OM - Oman	1
PE - Perù	1
TH - Thailandia	1
TL - Timor Orientale	1
TM - Turkmenistan	1
TW - Taiwan	1
Totale	2.281

Nome	#
Enhancement of Benzothiazoles as Pteridine Reductase-1 Inhibitors for the Treatment of Trypanosomatidic Infections	273
Profiling of flavonol derivatives for the development of antitrypanosomatidic drugs	263
Accelerating Drug Discovery Efforts for Trypanosomatidic Infections Using an Integrated Transnational Academic Drug Discovery Platform	263
Chroman-4-one derivatives targeting pteridine reductase 1 and showing anti-parasitic activity	261
Exploiting the 2-Amino-1,3,4-thiadiazole Scaffold To Inhibit Trypanosoma brucei Pteridine Reductase in Support of Early-Stage Drug Discovery	245
Development of flavonol and flavanone derivatives as anti-trypanosomatidic drugs	213
High-resolution crystal structure of Trypanosoma brucei pteridine reductase 1 in complex with an innovative tricyclic-based inhibitor	198
Structural Insights into the Development of Cycloguanil Derivatives as Trypanosoma brucei Pteridine-Reductase-1 Inhibitors	177
Repurposing the Trypanosomatidic GSK Kinetobox for the Inhibition of Parasitic Pteridine and Dihydrofolate Reductases	164
Multitarget, selective compound design yields potent inhibitors of a Kinetoplastid Pteridine Reductase 1	154
The discovery of aryl-2-nitroethyl triamino pyrimidines as anti-Trypanosoma brucei agents	128
Totale	2.339

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	68	0	0	0	0	0	0	0	0	0	20	9	39
2021/2022	150	3	22	17	19	9	4	6	10	7	9	15	29
2022/2023	152	8	9	26	11	16	38	3	14	18	2	5	2
2023/2024	189	9	3	17	14	4	50	61	3	2	6	0	20
2024/2025	324	12	15	30	11	40	28	8	16	35	11	38	80
2025/2026	912	55	130	129	169	187	28	81	23	59	51	0	0
Totale													2.339